Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry
Frontiers | Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar
Cureus | A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm
Determinants of seeding and spreading of α-synuclein pathology in the brain | Science Advances
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine
Biomolecules | Free Full-Text | Beyond the GFAP-Astrocyte Protein Markers in the Brain
Frontiers | Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
Biological Marker - an overview | ScienceDirect Topics
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
Frontiers | Roles of Neutrophils in Glioma and Brain Metastases
Pathology of brain tumours: the current state of diagnostic practice
Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
A New Avenue for Lithium: Intervention in Traumatic Brain Injury | ACS Chemical Neuroscience
BIOCHEMICAL MARKERS FOR MYOCARDIAL INFARCTION – Histopathology.guru
CSF and blood biomarkers for Parkinson's disease - The Lancet Neurology
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health: Trends in Molecular Medicine